ClinConnect ClinConnect Logo
Search / Trial NCT03179280

Effect of Dual-wave Insulin Bolus on Postprandial Glycaemia

Launched by ARISTOTLE UNIVERSITY OF THESSALONIKI · Jun 6, 2017

Trial Information

Current as of June 10, 2025

Completed

Keywords

Type 1 Diabetes Dual Wave Bolus Postprandial Euglycaemia

ClinConnect Summary

The nutritional recommendations of children and adolescents with T1D should be similar to those of healthy people in order to achieve the desirable growth. Not only the carbohydrates' intake is underlined according to special guidelines by Canadian diabetes association, American diabetes association and International Society for Paediatric and Adolescent Diabetes but also proteins and fats are suggested to be taken into consideration in the management of T1D. In order to reach the desirable euglycemic control, children and adolescents can use multiple daily injections (MDI) or continuous su...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • duration of T1D \>3 years, CSII therapy for at least 1 year, good to moderate glycaemic control, as evidenced by HbA1c levels \<8.5% (69 mmol/mol).
  • Exclusion Criteria:
  • Subjects with eating disorders, food allergy, celiac disease and known diabetic complications

About Aristotle University Of Thessaloniki

Aristotle University of Thessaloniki (AUTH) is a prestigious institution in Greece, renowned for its commitment to advancing knowledge and innovation in the field of clinical research. As a leading academic sponsor of clinical trials, AUTH leverages its extensive resources and expertise to conduct rigorous studies that contribute to the understanding of various medical conditions and the development of novel therapeutic interventions. The university fosters collaboration among multidisciplinary teams, ensuring adherence to the highest ethical standards and regulatory requirements while promoting scientific excellence and enhancing patient care.

Locations

Thessaloniki, , Greece

Patients applied

0 patients applied

Trial Officials

Assimina Galli-Tsinopoulou, Ass Prof

Study Chair

Unit of Pediatric Endocrinology, Diabetes and Metabolism-4th Department of Pediatrics, Medical School of Aristotle University of Thessaloniki

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials